Annual zoledronate increases bone density in highly active antiretroviral therapy-treated human immunodeficiency virus-infected men: a randomized controlled trial. [electronic resource]
Producer: 20070917Description: 1283-8 p. digitalISSN:- 0021-972X
- Adult
- Antiretroviral Therapy, Highly Active
- Body Mass Index
- Body Size
- Bone Density -- drug effects
- Bone Density Conservation Agents -- administration & dosage
- Diphosphonates -- administration & dosage
- Drug Administration Schedule
- HIV Infections -- drug therapy
- Humans
- Imidazoles -- administration & dosage
- Male
- Middle Aged
- Placebos
- Zoledronic Acid
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.